SIRT3 and colorectal carcinoma: SIRT3 is highly expressed in CRC cells leading to tumor resistance and poor overall survival [78, 79], with the reduction of protein expression resulting in cytotoxicity, cell death and impaired metabolic state and aggressiveness [42, 74].